Magellan Health Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Magellan Health (MGLN) Tops Q3 EPS by 18c, Revenues Beat; Offers FY20 EPS/Revenue Guidance
October 29, 2020 7:18 AM EDTMagellan Health (NASDAQ: MGLN) reported Q3 EPS of $0.08, $0.18 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.17 billion versus the consensus estimate of $1.14 billion.
Third Quarter 2020 and Recent Highlights:
Net revenue from continuing operations was $1.170 billion for the third quarter of 2020, an increase of 1.0% compared to the third quarter of 2019 primarily due to growth in the Pharmacy Management segment, partially offset by a decline in the Healthcare segment.Net loss from continuing operations was $17.3 million for the third quarter of 2020 compared to net income of $4.1 for... More